These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3877129

  • 21. Monoclonal antibody to a human salivary gland adenocarcinoma cell line: augmentation of antibody-dependent cell-mediated cytotoxicity activity by streptococcal preparation OK-432 in human salivary gland adenocarcinoma-bearing nude mice given the antibody.
    Kaji R, Yoshida H, Yanagawa T, Sato M.
    J Biol Response Mod; 1989 Oct; 8(5):488-500. PubMed ID: 2552025
    [Abstract] [Full Text] [Related]

  • 22. Effect of heat treatment on tumor cells and antitumor effector cells.
    Mise K, Kan N, Okino T, Nakanishi M, Satoh K, Teramura Y, Yamasaki S, Ohgaki K, Tobe T.
    Cancer Res; 1990 Oct 01; 50(19):6199-202. PubMed ID: 2400985
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T.
    Jpn J Exp Med; 1987 Apr 01; 57(2):103-15. PubMed ID: 3499533
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Differences in the immunostimulatory activity and antitumor therapeutic effect of OK-432 and N-CWS].
    Mizushima Y, Iwata M, Sato M, Hirata H, Takashima A, Yano S.
    Gan To Kagaku Ryoho; 1986 Jul 01; 13(7):2404-10. PubMed ID: 3729493
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Development of long-term cell lines and lymphoid clones reactive against murine and human tumors: a new approach to the adoptive immunotherapy of cancer.
    Rosenberg SA, Eberlein TJ, Grimm EA, Lotze MT, Mazumder A, Rosenstein M.
    Surgery; 1982 Aug 01; 92(2):328-36. PubMed ID: 6980492
    [Abstract] [Full Text] [Related]

  • 31. Effect of OK-432 on the lymphnode metastasis of MCA-sarcoma cell lines: a new therapeutic approach.
    Inoh A, Kodama Y, Yokoro K.
    Hiroshima J Med Sci; 1989 Dec 01; 38(4):213-9. PubMed ID: 2637250
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Down-regulation of IL-10 enhances the efficacy of locoregional immunotherapy using OK-432 against malignant effusion.
    Hihara J, Yamaguchi Y, Minami K, Noma K, Toge T.
    Anticancer Res; 1999 Dec 01; 19(2A):1077-84. PubMed ID: 10368657
    [Abstract] [Full Text] [Related]

  • 34. [Immunotherapy for lung cancer by streptococcal preparation OK-432].
    Watanabe Y, Shimizu J, Yoshida Y, Hashizume Y, Yamada T, Iwa T.
    Nihon Geka Gakkai Zasshi; 1989 Sep 01; 90(9):1432-5. PubMed ID: 2586434
    [Abstract] [Full Text] [Related]

  • 35. [Effect of immunotherapy using the non-specific immunopotentiator OK-432 in malignant ovarian tumors--selecting appropriate cases for immunotherapy].
    Nishida Y, Sakakibara K, Kano T, Ohta M, Tomoda Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul 01; 38(7):1017-25. PubMed ID: 3746020
    [Abstract] [Full Text] [Related]

  • 36. [Local immunotherapy with streptococcal preparation, OK-432 in superficial bladder tumors, and common antigens between OK-432 and the tumor].
    Fujioka T, Shiraishi M, Tanji S, Koike H, Suzuki K, Kumagai K, Aoki H, Sakuma Y, Ohhori T, Kubo T.
    Hinyokika Kiyo; 1989 Feb 01; 35(2):253-7. PubMed ID: 2735236
    [Abstract] [Full Text] [Related]

  • 37. The allogeneic effect on tumor growth. II. Suppression of both ascitic and solid MOPC 315 plasmacytoma by the graft-vs-host reaction, with pathologic correlation.
    Osborne DP, Katz DH.
    J Immunol; 1977 Apr 01; 118(4):1449-55. PubMed ID: 15035
    [Abstract] [Full Text] [Related]

  • 38. A new model of active specific immunotherapy using interleukin-1 and sonicated tumor supernatant in murine tumor system.
    Moriguchi Y, Kan N, Okino T, Harada T, Yamasaki S, Ichinose Y, Li L, Sugie T, Imamura M.
    J Surg Oncol; 1996 Jun 01; 62(2):78-85. PubMed ID: 8649045
    [Abstract] [Full Text] [Related]

  • 39. Therapeutic effect of OK-432 induced endogenous TNF on tumor bearing mice and cancer patients.
    Watanabe N, Niitsu Y, Yamauchi N, Neda H, Sone H, Urushizaki I, Yamamoto A, Nagamuta M, Sugawara Y.
    Immunopharmacol Immunotoxicol; 1988 Jun 01; 10(1):53-65. PubMed ID: 3361071
    [Abstract] [Full Text] [Related]

  • 40. Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice.
    Saito M, Nanjo M, Kataoka M, Moriya Y, Sugawara Y, Yoshida T, Ishida N.
    Cancer Res; 1988 Aug 01; 48(15):4163-7. PubMed ID: 3390809
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.